Whom to Biopsy Prediagnostic Risk Stratification with Biomarkers, Nomograms, and Risk Calculators

被引：19

作者：

Loeb, Stacy ^{[1
,2
,3
]}

Dani, Hasan ^{[4
]}

机构：

[1] NYU, Dept Urol, New York, NY USA

[2] NYU, Dept Populat Hlth, New York, NY USA

[3] Manhattan Vet Affairs Med Ctr, Dept Urol, New York, NY USA

[4] SUNY, Downstate Coll Med, Dept Urol, Brooklyn, NY USA

来源：

UROLOGIC CLINICS OF NORTH AMERICA | 2017年 / 44卷 / 04期

关键词：

Prostate cancer; Prostate-specific antigen; Biomarkers; Prostate biopsy; Nomograms; PROSTATE HEALTH INDEX; CANCER ANTIGEN 3; MOLECULAR URINE ASSAY; HIGH-GRADE CANCER; RADICAL PROSTATECTOMY; CLINICAL-PERFORMANCE; INTERNAL VALIDATION; EXTERNAL VALIDATION; ACTIVE SURVEILLANCE; KALLIKREIN MARKERS;

D O I：

10.1016/j.ucl.2017.07.001

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

This article describes markers used for prostate biopsy decisions, including prostrate-specific antigen (PSA), free PSA, the prostate health index, 4Kscore, PCA3, and ConfirmMDx. It also summarizes the use of nomograms combining multiple variables for prostate cancer detection.

引用

页码：517 / +

页数：9

共 50 条

[41] Risk stratification of prostate cancer in the modern era
Behesnilian, Andrew S.
Reiter, Robert E.
CURRENT OPINION IN UROLOGY, 2015, 25 (03) : 246 - 251
[42] Predictive models and risk of biopsy progression in active surveillance patients
Iremashvili, Viacheslav
Manoharan, Murugesan
Kava, Bruce R.
Parekh, Dipen J.
Punnen, Sanoj
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (02) : 37.e1 - 37.e8
[43] Prediction of Survival After Radical Cystectomy for Invasive Bladder Carcinoma: Risk Group Stratification, Nomograms or Artificial Neural Networks?
El-Mekresh, Mohsen
Akl, Ahmed
Mosbah, Ahmed
Abdel-Latif, Mohamed
Abol-Enein, Hassan
Ghoneim, Mohamed A.
JOURNAL OF UROLOGY, 2009, 182 (02) : 466 - 472
[44] Active Surveillance for Prostate Cancer: A Systematic Review of Clinicopathologic Variables and Biomarkers for Risk Stratification
Loeb, Stacy
Bruinsma, Sophie M.
Nicholson, Joseph
Briganti, Alberto
Pickles, Tom
Kakehi, Yoshiyuki
Carlsson, Sigrid V.
Roobol, Monique J.
EUROPEAN UROLOGY, 2015, 67 (04) : 619 - 626
[45] An analysis of three different prostate cancer risk calculators applied prior to prostate biopsy: A Turkish cohort validation study
Yildizhan, Mehmet
Balci, Melih
Eroglu, Unsal
Asil, Erem
Coser, Seref
Ozercan, Ali Yasin
Koseoglu, Burak
Guzel, Ozer
Asfuroglu, Ahmet
Tuncel, Altug
ANDROLOGIA, 2022, 54 (02)
[46] Combination Biomarkers for Risk Stratification in Patients With Chronic Heart Failure Biomarkers Prognostication in HF
Feng, Zekun
Akinrimisi, Olumuyiwa P.
Gornbein, Jeffrey A.
Truong, Quynh A.
Das, Saumya
Singh, Jagmeet P.
Ajijola, Olujimi
JOURNAL OF CARDIAC FAILURE, 2021, 27 (12) : 1321 - 1327
[47] Comparison of Two Prostate Cancer Risk Calculators that Include the Prostate Health Index
Roobol, Monique J.
Vedder, Moniek M.
Nieboer, Daan
Houlgatte, Alain
Vincendeau, Sebastien
Lazzeri, Massimo
Guazzoni, Giorgio
Stephan, Carsten
Semjonow, Axel
Haese, Alexander
Graefen, Markus
Steyerberg, Ewout W.
EUROPEAN UROLOGY FOCUS, 2015, 1 (02): : 185 - 190
[48] Feasibility and accuracy of prostate cancer risk calculators in prediction of prostate cancer, extraprostatic extension as well as the risk of lymph nodes metastasis
Kulik, Kacper
Brzoska, Rafal
Mazurek, Ewelina
Ostrowska, Magdalena
Ostrowski, Adam
Kowalski, Filip
Wilamowski, Jacek
Drewa, Tomasz
Adamowicz, Jan
Juszczak, Kajetan
CENTRAL EUROPEAN JOURNAL OF UROLOGY, 2023, 76 (01) : 20 - 24
[49] The role of biomarkers in the prognosis and risk stratification in heart failure: A systematic review
Singh, Gurmehar
Bamba, Hyma
Inban, Pugazhendi
Chandrasekaran, Sai Harini
Priyatha, Vemparala
John, Jobby
Prajjwal, Priyadarshi
DM DISEASE-A-MONTH, 2024, 70 (10):
[50] Biomarkers of risk stratification in congestive heart failure: North American view
Tang, W. H. Wilson
BIOMARKERS IN MEDICINE, 2009, 3 (05) : 443 - 452

← 1 2 3 4 5 →